The evolution of acute stroke care in Germany from 2019 to 2021: analysis of nation-wide administrative datasets.

Matthias N Ungerer, Dirk Bartig, Daniel Richter, Christos Krogias, Werner Hacke, Christoph Gumbinger
{"title":"The evolution of acute stroke care in Germany from 2019 to 2021: analysis of nation-wide administrative datasets.","authors":"Matthias N Ungerer, Dirk Bartig, Daniel Richter, Christos Krogias, Werner Hacke, Christoph Gumbinger","doi":"10.1186/s42466-023-00297-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The treatment of ischemic stroke (IS) has changed considerably in recent years. Particularly the advent of mechanical thrombectomy (MTE) has revolutionized the available treatment options. Most patients in developed countries have access to intravenous thrombolysis (IVT). However access to MTE remains restricted in some regions despite efforts to increase its availability. We performed an evaluation of national datasets to monitor improvements made in access to revascularization therapies for IS patients in Germany.</p><p><strong>Methods: </strong>We analyzed national datasets on German Diagnosis-Related Groups and structured quality reports by extracting information of patients admitted with stroke with and without IVT and MTE for the period of 2019-2021. Data from 2016 and limited data for 2022 were also included for comparison.</p><p><strong>Results: </strong>Admissions with ischemic stroke declined during the years of the COVID 19 pandemic by 4.5% from 227,258 in 2019 to 216,923 in 2021. IVT rates were stable with 16.3% being treated with IVT in 2019 and 2021. MTE rates continued to increase from 7.1 to 8.4% and the number of MTE centers increased by 14.8% in the same period. Over 87.3% of MTEs were performed in centers with a case volume exceeding 50 cases per year in 2021. The largest increase in the relative share of MTEs was seen in large MTE centers (n ≥ 200). Patient age for MTEs surpassed the age for IVTs in 2019 and the proportion of patients ≥ 80 years receiving MTE continued to increase. The proportion of regions in Germany with poor MTE rates (≤ 4.1%) decreased significantly from 2019 (12.3%) to 2021 (5.3%) (p < 0.001).</p><p><strong>Conclusions: </strong>We found strong evidence that while IVT rates reached a temporary ceiling effect, both the absolute number of and access to MTEs continued to increase in Germany. Regional disparities have become less significant and the majority of MTEs are performed in centers with medium or high case volumes.</p>","PeriodicalId":94156,"journal":{"name":"Neurological research and practice","volume":"6 1","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10782681/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological research and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42466-023-00297-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The treatment of ischemic stroke (IS) has changed considerably in recent years. Particularly the advent of mechanical thrombectomy (MTE) has revolutionized the available treatment options. Most patients in developed countries have access to intravenous thrombolysis (IVT). However access to MTE remains restricted in some regions despite efforts to increase its availability. We performed an evaluation of national datasets to monitor improvements made in access to revascularization therapies for IS patients in Germany.

Methods: We analyzed national datasets on German Diagnosis-Related Groups and structured quality reports by extracting information of patients admitted with stroke with and without IVT and MTE for the period of 2019-2021. Data from 2016 and limited data for 2022 were also included for comparison.

Results: Admissions with ischemic stroke declined during the years of the COVID 19 pandemic by 4.5% from 227,258 in 2019 to 216,923 in 2021. IVT rates were stable with 16.3% being treated with IVT in 2019 and 2021. MTE rates continued to increase from 7.1 to 8.4% and the number of MTE centers increased by 14.8% in the same period. Over 87.3% of MTEs were performed in centers with a case volume exceeding 50 cases per year in 2021. The largest increase in the relative share of MTEs was seen in large MTE centers (n ≥ 200). Patient age for MTEs surpassed the age for IVTs in 2019 and the proportion of patients ≥ 80 years receiving MTE continued to increase. The proportion of regions in Germany with poor MTE rates (≤ 4.1%) decreased significantly from 2019 (12.3%) to 2021 (5.3%) (p < 0.001).

Conclusions: We found strong evidence that while IVT rates reached a temporary ceiling effect, both the absolute number of and access to MTEs continued to increase in Germany. Regional disparities have become less significant and the majority of MTEs are performed in centers with medium or high case volumes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019 年至 2021 年德国急性中风护理的演变:全国行政数据集分析。
背景:近年来,缺血性中风(IS)的治疗方法发生了很大变化。特别是机械性血栓切除术(MTE)的出现彻底改变了现有的治疗方案。发达国家的大多数患者都能接受静脉溶栓治疗(IVT)。然而,尽管人们努力提高机械溶栓术的可用性,但在一些地区,机械溶栓术的使用仍然受到限制。我们对全国数据集进行了评估,以监测德国 IS 患者在获得血管重建疗法方面的改善情况:我们分析了德国诊断相关组的国家数据集和结构化质量报告,提取了2019-2021年期间使用或未使用IVT和MTE的中风入院患者的信息。2016年的数据和2022年的有限数据也被纳入其中进行比较:结果:在 COVID 19 大流行期间,缺血性脑卒中入院人数下降了 4.5%,从 2019 年的 227 258 人降至 2021 年的 216 923 人。IVT 率保持稳定,2019 年和 2021 年有 16.3% 的患者接受了 IVT 治疗。同期,MTE 率继续从 7.1% 上升至 8.4%,MTE 中心的数量增加了 14.8%。2021 年,超过 87.3% 的 MTE 是在每年病例量超过 50 例的中心进行的。大型 MTE 中心(n ≥ 200)的 MTE 相对份额增幅最大。2019年,MTE的患者年龄超过了IVT的患者年龄,接受MTE的≥80岁患者比例继续增加。德国 MTE 率较低(≤ 4.1%)的地区比例从 2019 年(12.3%)到 2021 年(5.3%)显著下降(p 结论:我们发现了强有力的证据,表明虽然 IVT 率达到了暂时的天花板效应,但德国的 MTE 绝对数量和获得 MTE 的机会都在继续增加。地区差异已变得不那么明显,大多数 MTE 在病例量中等或高的中心进行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.40
自引率
0.00%
发文量
0
审稿时长
14 weeks
期刊最新文献
Ischemia/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments. Letter to the editor in response to Professor Josef Finsterer. MS brain health quality standards: a survey on the reality in clinical practice in Germany. Chikungunya-related Guillain-Barre syndrome is most commonly demyelinating and affects multiple cranial nerves. Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1